HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-JUN-21 7N4Q TITLE BRUTON'S TYROSINE KINASE IN COMPLEX WITH COMPOUND 45 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TRANSFERASE, TRANSFERASE INHIBITOR, KINASE, KINASE INHIBITOR, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.METRICK,D.J.MARCOTTE REVDAT 2 18-OCT-23 7N4Q 1 REMARK REVDAT 1 18-MAY-22 7N4Q 0 JRNL AUTH B.T.HOPKINS,E.BAME,N.BELL,T.BOHNERT,J.K.BOWDEN-VERHOEK, JRNL AUTH 2 M.BUI,M.T.CANCILLA,P.CONLON,P.CULLEN,D.A.ERLANSON,J.FAN, JRNL AUTH 3 T.FUCHS-KNOTTS,S.HANSEN,S.HEUMANN,T.J.JENKINS,C.GUA,Y.LIU, JRNL AUTH 4 Y.LIU,M.LULLA,D.MARCOTTE,I.MARX,B.MCDOWELL,E.MERTSCHING, JRNL AUTH 5 E.NEGROU,M.J.ROMANOWSKI,D.SCOTT,L.SILVIAN,W.YANG,M.ZHONG JRNL TITL UTILIZING STRUCTURE BASED DRUG DESIGN AND METABOLIC SOFT JRNL TITL 2 SPOT IDENTIFICATION TO OPTIMIZE THE IN VITRO POTENCY AND IN JRNL TITL 3 VIVO PHARMACOKINETIC PROPERTIES LEADING TO THE DISCOVERY OF JRNL TITL 4 NOVEL REVERSIBLE BRUTON'S TYROSINE KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 44 16275 2021 JRNL REFN ESSN 1464-3391 JRNL PMID 34314938 JRNL DOI 10.1016/J.BMC.2021.116275 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122+SVN REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 5.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 42935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 2164 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 25.4300 - 3.7000 0.89 2887 129 0.1695 0.2022 REMARK 3 2 3.7000 - 2.9400 0.92 2820 140 0.1828 0.2106 REMARK 3 3 2.9300 - 2.5600 0.88 2639 157 0.1919 0.2149 REMARK 3 4 2.5600 - 2.3300 0.84 2523 117 0.1888 0.2184 REMARK 3 5 2.3300 - 2.1600 0.84 2513 148 0.1763 0.2118 REMARK 3 6 2.1600 - 2.0400 0.86 2548 134 0.1858 0.2069 REMARK 3 7 2.0400 - 1.9300 0.89 2644 140 0.1775 0.2222 REMARK 3 8 1.9300 - 1.8500 0.91 2691 140 0.1912 0.2411 REMARK 3 9 1.8500 - 1.7800 0.93 2737 159 0.2007 0.2301 REMARK 3 10 1.7800 - 1.7200 0.94 2765 152 0.1905 0.1981 REMARK 3 11 1.7200 - 1.6600 0.96 2816 140 0.1844 0.2438 REMARK 3 12 1.6600 - 1.6200 0.94 2791 148 0.2007 0.2332 REMARK 3 13 1.6200 - 1.5700 0.96 2838 145 0.2391 0.2953 REMARK 3 14 1.5700 - 1.5400 0.97 2851 150 0.3288 0.3403 REMARK 3 15 1.5400 - 1.5000 0.93 2708 165 0.4357 0.4219 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.227 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.562 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2192 REMARK 3 ANGLE : 0.962 2975 REMARK 3 CHIRALITY : 0.057 319 REMARK 3 PLANARITY : 0.009 375 REMARK 3 DIHEDRAL : 13.963 816 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7N4Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1000255236. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42987 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 38.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3GEN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BISTRIS PH 6.5, 0.2M AMMONIUM REMARK 280 ACETATE, 0.1M GUANIDINE HCL, 20% PEG2200 MME, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.04400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.40100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.04400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.40100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 391 REMARK 465 ASP A 549 REMARK 465 GLU A 550 REMARK 465 TYR A 551 REMARK 465 THR A 552 REMARK 465 SER A 553 REMARK 465 SER A 554 REMARK 465 VAL A 555 REMARK 465 SER A 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 PHE A 413 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 433 CG CD CE NZ REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 VAL A 448 CG1 CG2 REMARK 470 ASN A 451 CG OD1 ND2 REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 GLN A 516 CG CD OE1 NE2 REMARK 470 ASP A 548 CG OD1 OD2 REMARK 470 SER A 557 OG REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 GLU A 624 CG CD OE1 OE2 REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 GLU A 657 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -41.41 -140.25 REMARK 500 ARG A 520 -10.12 79.69 REMARK 500 ASP A 521 52.84 -149.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1079 DISTANCE = 5.91 ANGSTROMS DBREF 7N4Q A 391 659 UNP Q06187 BTK_HUMAN 391 659 SEQRES 1 A 269 GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR SEQRES 2 A 269 PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL SEQRES 3 A 269 LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE SEQRES 4 A 269 LYS MET ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE SEQRES 5 A 269 ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU SEQRES 6 A 269 LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG SEQRES 7 A 269 PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS SEQRES 8 A 269 LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN SEQRES 9 A 269 THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU SEQRES 10 A 269 ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG SEQRES 11 A 269 ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY SEQRES 12 A 269 VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL SEQRES 13 A 269 LEU ASP ASP GLU TYR THR SER SER VAL GLY SER LYS PHE SEQRES 14 A 269 PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER SEQRES 15 A 269 LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL SEQRES 16 A 269 LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR SEQRES 17 A 269 GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA SEQRES 18 A 269 GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU SEQRES 19 A 269 LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS SEQRES 20 A 269 ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN SEQRES 21 A 269 ILE LEU ASP VAL MET ASP GLU GLU SER HET 0B9 A 701 31 HETNAM 0B9 (2R)-2-(3-CHLORO-5-FLUOROANILINO)-2-CYCLOPROPYL-N- HETNAM 2 0B9 [(3R)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-3- HETNAM 3 0B9 YL]ACETAMIDE FORMUL 2 0B9 C22 H24 CL F N6 O FORMUL 3 HOH *279(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 MET A 450 1 13 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 0.92 CRYST1 72.088 104.802 38.183 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013872 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009542 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026190 0.00000